EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -31.34% | 27.36% | |||
| Total Other Revenue | 47.28% | 42.69% | |||
| Total Revenue | 9.20% | 34.74% | |||
| Cost of Revenue | -37.21% | 28.54% | |||
| Gross Profit | 34.25% | 38.46% | |||
| SG&A Expenses | -49.17% | 18.80% | |||
| Depreciation & Amortization | 0.00% | -1.01% | |||
| Other Operating Expenses | -- | 318.00% | |||
| Total Operating Expenses | -48.21% | 21.20% | |||
| Operating Income | 70.57% | -16.61% | |||
| Income Before Tax | -126.86% | 462.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -126.86% | 462.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -126.86% | 527.18% | |||
| EBIT | 70.57% | -16.61% | |||
| EBITDA | 73.62% | -17.51% | |||
| EPS Basic | -126.67% | 512.50% | |||
| Normalized Basic EPS | 53.45% | -163.64% | |||
| EPS Diluted | -126.67% | 512.50% | |||
| Normalized Diluted EPS | 53.45% | -163.64% | |||
| Average Basic Shares Outstanding | 0.81% | 2.34% | |||
| Average Diluted Shares Outstanding | 0.81% | 2.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
